Discontinuation report CEFZIL POWDER FOR ORAL SUSPENSION-125MG/5ML

Last updated on 2017-12-30 History
Report ID 11847
Drug Identification Number 02163675
Brand name CEFZIL POWDER FOR ORAL SUSPENSION-125MG/5ML
Common or Proper name Cefprozil
Company Name BRISTOL-MYERS SQUIBB CANADA
Market Status CANCELLED POST MARKET
Active Ingredient(s) CEFPROZIL
Strength(s) 125MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration ORAL
Packaging size 1 BTL X 75 mL and 1 BTL X 100 ML
ATC code J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-12-29
Remaining supply date 2017-12-29
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
MONTRÉAL (ST-LAURENT), QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2017-12-30 English Compare
v2 2017-06-05 French Compare
v1 2017-06-05 English Compare